DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE Drug Patent Profile
✉ Email this page to a colleague
When do Dorzolamide Hydrochloride And Timolol Maleate patents expire, and what generic alternatives are available?
Dorzolamide Hydrochloride And Timolol Maleate is a drug marketed by Alembic, Bausch And Lomb, Chartwell Molecular, Epic Pharma Llc, Eugia Pharma, Fdc Ltd, Gland Pharma Ltd, Hikma, Indoco, Ingenus Pharms Llc, Micro Labs, Rubicon, Sandoz, Somerset, Teva Pharms, and Zambon Spa. and is included in nineteen NDAs.
The generic ingredient in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE is dorzolamide hydrochloride; timolol maleate. There are fifteen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the dorzolamide hydrochloride; timolol maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dorzolamide Hydrochloride And Timolol Maleate
A generic version of DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE was approved as dorzolamide hydrochloride; timolol maleate by SANDOZ on November 6th, 2008.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE?
- What are the global sales for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE?
- What is Average Wholesale Price for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE?
Summary for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 19 |
| Finished Product Suppliers / Packagers: | 15 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 9 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE? | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE excipients list |
| DailyMed Link: | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE at DailyMed |
Recent Clinical Trials for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Florida | Phase 1 |
| Allergan | Phase 3 |
| Allergan | Phase 4 |
See all DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE clinical trials
Pharmacology for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
| Drug Class | Carbonic Anhydrase Inhibitor beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists Carbonic Anhydrase Inhibitors |
US Patents and Regulatory Information for DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 213099-001 | May 4, 2021 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 078704-001 | Sep 28, 2009 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fdc Ltd | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 205295-001 | Jun 13, 2019 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Epic Pharma Llc | DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE | dorzolamide hydrochloride; timolol maleate | SOLUTION/DROPS;OPHTHALMIC | 203058-001 | Sep 22, 2014 | AT1 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
